Allied Market Research
Loading...
0
Upcoming Allied Market Research
2022
Drug Discovery Outsourcing Market

Drug Discovery Outsourcing Market by drug type (Small molecules, large molecules, and Biologics), Workflow (Target identification and screening, Target validation and functional informatics, Lead identification and candidate optimization, Preclinical development, and Others), and Application (Hospitals and Clinics, Medical Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A14914
Pages: NA
Feb 2022 | 47 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Drug Discovery Outsourcing Market

Request Now !

Drug discovery outsourcing is a process that is used for finding new drugs or medicines in various fields of pharmaceuticals, pharmacology, and biotechnology. Also, outsourcing of drug discovery is the beginning phase of the drug development process.

The increase in the trends of partnerships in drug discovery research is one of the most important factors that intensify the demand and growth of the drug discovery outsourcing market globally. Additionally, the rising prevalence rate of genetic, metabolic, and other chronic diseases and advancements in technology, the discovery and research for drugs are the factors that contribute to the growth of the market in the forecast timeline. Also, increased usage of AI in the discovery of the drugs as well as the shift in the patent biologics, expiration, and unprecedented downsizing of internal discovery of major pharmaceuticals are likely to enhance the market growth.

Rising incidences of drug resistance as well as antibiotic resistance will boost the market in the forecast timeline.

Market Scope and Structure Analysis:

Report Metric 

Details

 Market size available for years

  2021–2030

  Base year considered

  2020

  Forecast period

  2021–2030

  Forecast units

  Value (USD)

  Segments covered

  Drug Type, Workflow, Application, and Region

  Companies covered

Major players analyzed include Charles River, Domainex, EVOTEC, GenScript, GVK Biosciences, Laboratory Corporation of America. Charles River Laboratories, Albany Molecular Research Inc., Thermo Fisher Scientific, Jubilant Biosys, Eurofins Scientific, GVK Biosciences Private Limited, Aurigene Pharmaceutical Services Ltd., Selvita, Dalton Pharma Services, QIAGEN, Syngene International Limited, SRI INTERNATIONAL, Merck KGaA, Covance Inc., Nanosyn, Bioduro, Sygnature Discovery, Laboratory Corporation of America Holdings, Domainnex and GenScript.

 

COVID-19 Scenario Analysis: 

The outbreak of COVID-19 is likely to have a moderate impact on the market in the forecast period. Research and development activities to identify the threat of SARS-CoV-2 virus on the patients suffering are likely to slow the market growth.
COVID-19 has brought about a significant burden on the global healthcare industry with disruption in the treatment of non-communicable diseases. Challenges exist in providing effective care.

Realizing the disturbing healthcare trends, governments are making efforts to provide excellent quality healthcare to patients globally. Nationwide lockdowns, canceled or postponed elective surgeries, denied wound care services, rise in skin injuries may lead to a decline during the forecast timeline. However, on the flip side, the latter half of the forecast is predicted to show a drastic rise.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Pharmaceutical companies are now outsourcing research and development activities to private Contract Research Organizations (CRO) and academic institutions to reduce drug development time and cost. The pharmaceutical sector has witnessed radical changes in the past few decades, like patent expiration, the shift towards biologics and unprecedented downsizing of internal discovery of major pharmaceutical companies. All of this has accelerated the growth of the drug discovery outsourcing market. An estimate states that approximately 75.0 to 80% of research and development activities in the pharmaceutical sector can be outsourced, which will create opportunities for CROs, and on the flip side will boost the growth of the market.

Additionally, breaking down various steps of drug discovery, like lead generation, high-speed screening, lead optimization, and hit conformation allows companies to expertise in their core service. Pharmaceutical companies are collaborating with manufacturing services in emerging economies because of the low cost of manpower with the availability of a skilled workforce and quality data. Chasing innovation, cost-cutting, gaining access to specialized technology and knowledge, and rising agility and speed are some of the important factors that are attracting pharma companies to expand the level of outsourcing.

The increasing need for skilled resources and combinational knowledge of metabolism, computer software and analytical chemistry, along with the high cost of latest computation technology, is likely lead to higher outsourcing for lead identification services. This will fuel the growth of the market over the forecast timeline. The other associated services segment like upstream and downstream processes, cell line development, analytical/bioanalytical methods, regulatory assistance, formulations & quality assistance is predicted to witness rapid growth in the forecast timeline. This on the flip side increases the adoption of outsourcing services with high investments in drug discovery research.

North America dominated the highest market share due to factors like the presence of well-established research infrastructure, adoption of technological advancements, presence of key players and huge research and development investments, which is likely to augment the region's growth. Asia-Pacific is anticipated to be the most lucrative and rapidly growing market for outsourcing of drug discovery activities due to the favorable regulatory environment and availability of low-cost skilled manpower with high-quality data. Japan, being the second-largest pharmaceutical hub, is predicted to provide growth opportunities for CROs, which will drive the overall market of Asia-Pacific.

Key Benefits of the Report:

  • This study presents the analytical depiction of the global drug discovery outsourcing market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global drug discovery outsourcing market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the global drug discovery outsourcing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global drug discovery outsourcing market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions Answered in the Drug Discovery Outsourcing Market Research Report:

  • What are the leading market players active in the drug discovery outsourcing market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Key Market Segments

Segments Sub-segments
Drug Type
  • Small molecules
  • large molecules
  • Biologics
Workflow
  • Target identification and screening
  • Target validation and functional informatics
  • Lead identification and candidate optimization
  • Preclinical development
  • Others
therapeutic area
  • Respiratory system
  • Oncology
  • Ophthalmology
  • Haematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central nervous system
  • Dermatology
  • Genitourinary system
Application
  • Hospitals and Clinics
  • Medical Laboratories
  • Others
Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
  • Rest of LAMEA
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Drug Discovery Outsourcing Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers